Surgery Partners, Inc.
SGRY
$24.05
-$0.11-0.46%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -76.68% | 37.87% | 100.65% | 78.21% | -9.58% |
Total Depreciation and Amortization | 28.47% | 9.36% | -2.48% | 2.87% | 8.06% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 29.50% | 21.54% | -4.04% | -3.16% | -1.06% |
Change in Net Operating Assets | -75.37% | 29.24% | 19.86% | 60.49% | 42.30% |
Cash from Operations | 5.41% | 77.80% | 69.38% | 85.01% | 39.17% |
Capital Expenditure | 4.14% | 3.88% | 1.38% | -10.17% | -27.36% |
Sale of Property, Plant, and Equipment | -96.12% | -96.92% | -7.66% | 100.00% | 1,005.71% |
Cash Acquisitions | -186.32% | -161.83% | 39.81% | 45.36% | 57.89% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 64.78% | 76.15% | 28.99% | 11.94% | 17.48% |
Cash from Investing | -81.44% | -53.09% | 28.21% | 26.73% | 43.69% |
Total Debt Issued | 659.09% | 803.62% | 352.30% | 279.52% | 396.53% |
Total Debt Repaid | -103.79% | -103.37% | -5.87% | 6.37% | -821.70% |
Issuance of Common Stock | -- | -- | -- | -- | 175.13% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 3.02% | 4.96% | 12.60% | 11.14% | 2.26% |
Cash from Financing | 105.33% | 184.70% | -284.53% | -468.65% | 4.70% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -117.49% | 172.20% | 54.80% | 18.69% | 146.24% |